The Enterprise Value as of December 2025 (TTM) for GeneFerm Biotechnology Co., Ltd. (1796.TWO) is 2.04B

According to GeneFerm Biotechnology Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.04B. This represents a change of -2.28% compared to the average of 2.08B of the last 4 quarters.

GeneFerm Biotechnology Co., Ltd. (1796.TWO) Historical Enterprise Value (quarterly & annually)

How has 1796.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of GeneFerm Biotechnology Co., Ltd. over the last ten years is 2.02B. The current 2.04B Enterprise Value has changed 9.99% with respect to the historical average. Over the past ten years (40 quarters), 1796.TWO's Enterprise Value was at its highest in in the June 2023 quarter at 4.50B. The Enterprise Value was at its lowest in in the March 2025 quarter at 2.07B.

GeneFerm Biotechnology Co., Ltd. (1796.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of GeneFerm Biotechnology Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GeneFerm Biotechnology Co., Ltd. (1796.TWO) Average Enterprise Value

How has 1796.TWO Enterprise Value performed in the past?

The current Enterprise Value of GeneFerm Biotechnology Co., Ltd. (1796.TWO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

GeneFerm Biotechnology Co., Ltd. (1796.TWO) Enterprise Value vs. Peers

How is 1796.TWO’s Enterprise Value compared to its peers?

GeneFerm Biotechnology Co., Ltd.’s Enterprise Value is greater than LIWANLI Innovation Co., Ltd. (1.71B), greater than Winston Medical Supply Co., Ltd. (1.40B), greater than TSH Biopharm Corporation Limited (1.62B), less than InnoPharmax Inc. (2.10B), less than Golden Biotechnology Corporation (5.82B), less than Allied Biotech Corporation (2.28B), greater than Crystalvue Medical Corporation (1.86B), less than Sunny Pharmtech Inc. (2.46B), less than BenQ Medical Technology Corporation (3.15B), less than OK Biotech Co., Ltd. (2.98B),

Build a custom stock screener for GeneFerm Biotechnology Co., Ltd. (1796.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeneFerm Biotechnology Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GeneFerm Biotechnology Co., Ltd. (1796.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GeneFerm Biotechnology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.